image credit: Unsplash

AngioDynamics Submits 510(k) Application to FDA for AlphaVac Mechanical Thrombectomy System

April 12, 2021

Via: BioSpace

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology today announced that on April 9, 2021, it submitted a 510(k) application to the United States Food and Drug Administration (FDA) for the AlphaVac System, an off-circuit, multi-purpose mechanical aspiration thrombectomy device for the treatment of undesirable intravascular material in the venous system and peripheral vasculature.

Read More on BioSpace